DOI:
10.1055/s-00000094
Zeitschrift für Gastroenterologie
LinksClose Window
References
Saltz L. et al.
Phase III trial of cetuximab, bevacizumab, and 5-fluorouracil/leucovorin vs. FOLFOX-bevacizumab in colorectal cancer.
Clin Colorectal Cancer 2012;
11: 101-111
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.